BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2536881)

  • 1. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
    Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice.
    Zarrindast MR; Bayat A; Shafaghi B
    Gen Pharmacol; 1993 Jan; 24(1):127-30. PubMed ID: 8097737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR; Eliassi A
    Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS; Starr BS
    Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of distinct D2 dopaminergic and alpha 2-adrenergic receptors induces light-adaptive pigment dispersion in teleost retinal pigment epithelium.
    Dearry A; Burnside B
    J Neurochem; 1988 Nov; 51(5):1516-23. PubMed ID: 2844995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice.
    Goodale DB; Jacobi AG; Seyfried DM; Weiss B
    Pharmacol Biochem Behav; 1988 Jun; 30(2):457-62. PubMed ID: 2902647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS; Starr MS; Kilpatrick IC
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
    Leander JD
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR; Tabatabai SA
    Psychopharmacology (Berl); 1992; 107(2-3):341-6. PubMed ID: 1535446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB; Jackson DM; Wallis EM; Edwards SR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
    Arnt J; Hyttel J
    J Neural Transm; 1986; 67(3-4):225-40. PubMed ID: 2949056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.